The Beauty & Personal Care (BPC) sector has long delivered strong growth, ahead of the wider CPG landscape. Its combination of emotional engagement, innovation, and high-margin categories made it an attractive one for investment. However, it has historically been largely inaccessible to other investors, dominated instead by a small number of Strategics using M&A to access growth and maintain portfolio relevance.
That dynamic is now shifting. Strategic buyers are pulling back, the M&A model that once propelled beauty is challenged, and in the disruption that’s followed, a new window is opening — one that may allow a different breed of investor to participate.
From 2005 to 2019, beauty M&A was overwhelmingly led by strategics:
This “spread bet” approach delivered returns, with the only real downside being saturated portfolios. For example, by the late 2010s, Unilever held 35% of the U.S. haircare market through overlapping brands.
The pandemic disrupted the category — and temporarily supercharged it:
As a result, relatively nascent brands like Rare Beauty, Hero, and Olaplex posted >100% YoY growth.
A burst in M&A followed:
This acceleration came to a halt as the dynamics that had fuelled it quickly changed:
The deterioration in performance was stark, and Strategics recorded significant impairments against their assets (more than £10bn across ~30 beauty assets).
This slowdown in performance clashed with elevated valuations expectations. As a result, Strategics retrenched and deal volumes fell below historical norms.
Strategic acquirers remain active — but are far more selective. Assets must now check all of the following boxes:
Put simply, there is much more emphasis on quality of growth over quantity.
When an asset clears these hurdles, there is a strong appetite (e.g., Charlotte Tilbury, Amouage, Medik8, Rhode). But many high-quality assets — Rare Beauty, Tree Hut, Byoma — have struggled to find an acquirer.
There remains significant interest to deploy capital in the sector from a variety of investor types, so vendors should be able to generate interest. However, there are hurdles for new investors to overcome too which sellers would do well to consider more proactively.
These range from the relatively obvious and potentially temporary – inflated cost of capital and elevated valuations – to more esoteric: after years of limited participation in the space, there is a higher degree of caution in investing in high-growth, emotionally led brands.
Investors looking at the category for the first time are typically apprehensive about the potential for fad risk and cannot generate the confidence in a brand’s true potential to expand beyond their core consumer groups and categories.
To help give buyers this conviction (and so the ability to navigate their own internal investment committees), it is incumbent on assets to be front footed in answering these questions with tangible proof points. Without this, conservativism is likely to win out.
In this context, is it possible for a new model to emerge — blending the strengths of corporates and financial sponsors:
There are already some players who may be deploying something similar to this. For example, Yellow Wood’s acquisition of Suave and Elida Beauty is building a scale entity in the US which could make targeted bolt-on acquisitions; Blackstone’s investment in L’Occitane also provides a strong base from which to participate in the industry more actively.
Need an edge in your next beauty acquisition? Let us help shape your investment thesis. Discover more of our insights and contact our experts today, or email [email protected]
Partner
Associate Partner
要访问完整报告,请填写以下表格。
"*" indicates required fields